Business & Finance
Victrex Stock Soars 14% as Profit Outlook Improves Under CEO's Recovery Strategy
Shares of Victrex climbed as much as 14% on Wednesday following an upgraded full-year profit forecast from the specialty chemicals company, signaling early success for chief executive James Routh's turnaround efforts. The Thornton-Cleveleys-based firm, which produces PEEK and PAEK high-performance polymers used in aerospace, automotive, electronics, and medical device manufacturing, issued a pre-close trading update ahead of Wednesday's market open. In it, the company revised its FY2026 underlying pre-tax profit expectations upward to a range of £45 million to £47 million, compared to its earlier projection of £42 million to £44 million. This improved outlook reflects sustained momentum through the fourth quarter, building on an update issued in early July. The revised guidance represents a notable shift from earlier struggles. During the first half of the financial year, Victrex had posted an 18% decline in underlying pre-tax profit, falling to £19 million, and recorded a reported pre-tax loss of £44 million following a £60.6 million non-cash impairment charge related to its Panjin, China manufacturing facility. Wednesday's announcement provides the first concrete evidence that the promised turnaround is taking hold. According to the company, growth has been widespread across its Aerospace, VARs, and Electronics segments, as well as across all geographic regions, with the Asia-Pacific market showing particular strength. Victrex also credited early gains from a completed workforce reduction of 10%, which forms part of a broader Profit Improvement Plan aimed at achieving at least £10 million in annualized savings by FY2027. Dr James Routh, the company's chief executive, stated: "We have maintained our strong momentum during Q4, with revenue growth driven by improved performance across key end markets and all regions. As a result, we now expect full year underlying PBT for FY 2026 to be ahead of our prior guidance." The stock market responded swiftly, with share prices jumping from Tuesday's closing figure of 869p to approximately 991p-993p, reaching an intraday peak near 1,018p. This surge pushed shares to a new 52-week high, surpassing the previous high of 874.99p recorded earlier in the year. Additional details regarding the company's strategic direction are expected to be revealed at an upcoming Capital Markets Event titled "Unlocking Victrex's Potential," set to take place in London on September 24.